Outset Medical (OM) Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" OM shares.
View OM analyst ratings or view top-rated stocks.

4 brokerages have issued twelve-month target prices for Outset Medical's shares. Their OM share price forecasts range from $19.00 to $29.00. On average, they anticipate the company's share price to reach $24.20 in the next year. This suggests a possible upside of 122.4% from the stock's current price.
View analysts price targets for OM or view top-rated stocks among Wall Street analysts.

Outset Medical's stock was trading at $25.82 on January 1st, 2023. Since then, OM shares have decreased by 57.9% and is now trading at $10.88.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our OM earnings forecast.

Outset Medical, Inc. (NASDAQ:OM) posted its quarterly earnings data on Wednesday, August, 2nd. The company reported ($0.90) EPS for the quarter, missing analysts' consensus estimates of ($0.85) by $0.05. The business had revenue of $36.04 million for the quarter, compared to analysts' expectations of $35.18 million. Outset Medical had a negative trailing twelve-month return on equity of 73.66% and a negative net margin of 131.69%.

ETFs with the largest weight of Outset Medical (NASDAQ:OM) stock in their portfolio include Procure Disaster Recovery Strategy ETF (FIXT), Procure Disaster Recovery Strategy ETF (FEMA), BNY Mellon Innovators ETF (BKIV), SPDR S&P Health Care Equipment ETF (XHE) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Medical Devices ETF (IHI).

Outset Medical issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $144.00 million-$150.00 million, compared to the consensus revenue estimate of $147.35 million.

(OM) raised $175 million in an initial public offering (IPO) on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Outset Medical trades on the NASDAQ under the ticker symbol "OM."

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OM stock can currently be purchased for approximately $10.88.

Outset Medical (NASDAQ:OM) has a market capitalization of $541.72 million and generates $115.38 million in revenue each year. The company earns $-162,960,000.00 in net income (profit) each year or ($3.51) on an earnings per share basis.

The company employs 518 workers across the globe.

Outset Medical's mailing address is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. The official website for the company is outsetmedical.com. The company can be reached via phone at 669-231-8200 or via email at investors@outsetmedical.com.